Exelixis Announces Webcast Of January 15 Presentation At The J.P. Morgan 32nd Annual Healthcare Conference

Exelixis, Inc. (NASDAQ:EXEL) today announced that Michael M. Morrissey, Ph.D., the company’s president and chief executive officer, will present at the J.P. Morgan 32 nd Annual Healthcare Conference at 5:00 p.m. EST / 2:00 p.m. PST on Wednesday, January 15, 2014, in San Francisco. During the presentation, Dr. Morrissey will review the company’s development plans and priorities for cabozantinib in 2014. He will also discuss the company’s corporate strategy and financial outlook, and provide a general business update.

The presentation will be webcast and may be accessed via the Event Calendar page under Investors & Media at www.exelixis.com.

About Exelixis

Exelixis, Inc. is a biotechnology company committed to developing small molecule therapies for the treatment of cancer. Exelixis is focusing its proprietary resources and development efforts exclusively on COMETRIQ® (cabozantinib). Exelixis has also established a portfolio of other novel compounds that it believes have the potential to address serious unmet medical needs, many of which are being advanced by partners as part of collaborations. For more information, please visit the company's web site at www.exelixis.com.

Exelixis, the Exelixis logo, and COMETRIQ are registered U.S. trademarks.

Copyright Business Wire 2010

If you liked this article you might like

Anthem, A.O. Smith, Tableau Software: 'Mad Money' Lightning Round

Anthem, A.O. Smith, Tableau Software: 'Mad Money' Lightning Round

Cramer Calls It a Market Reset: 'Mad Money' Recap (Monday 2/5/18)

Cramer Calls It a Market Reset: 'Mad Money' Recap (Monday 2/5/18)

New Records for Dow, S&P 500 and Nasdaq as Apple's Gains Offset Healthcare Slide

New Records for Dow, S&P 500 and Nasdaq as Apple's Gains Offset Healthcare Slide

Dow, Nasdaq on Track for Records as Energy and Apple Rise

Dow, Nasdaq on Track for Records as Energy and Apple Rise

Stocks Rise but Come Off Highs as Crude Gains Ease

Stocks Rise but Come Off Highs as Crude Gains Ease